NYSEArca - Delayed Quote USD

Virtus LifeSci Biotech Products ETF (BBP)

55.33
+1.24
+(2.29%)
At close: May 16 at 1:21:05 PM EDT

Top 10 Holdings (22.92% of Total Assets)

SymbolCompany% Assets
TG Therapeutics, Inc. 2.58%
BeiGene, Ltd. 2.50%
BridgeBio Pharma, Inc. 2.41%
Kiniksa Pharmaceuticals International, plc 2.33%
Ascendis Pharma A/S 2.27%
Sage Therapeutics, Inc. 2.24%
Halozyme Therapeutics, Inc. 2.23%
ADMA Biologics, Inc. 2.22%
SpringWorks Therapeutics, Inc. 2.08%
Axsome Therapeutics, Inc. 2.07%

Sector Weightings

SectorBBP
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.61%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.28
Price/Sales 0.18
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with at least one drug therapy approved by the U.S. Food and Drug Administration ("FDA") for marketing.

ETF Overview

Category Health
Fund Family Virtus
Net Assets 23.61M
YTD Daily Total Return -9.88%
Yield 0.00%
Legal Type Exchange Traded Fund

Related Tickers